Robb E. Wilentz - Concepedia

Author

Robb E. Wilentz

Johns Hopkins University

Also Known As

R E Wilentz, R. E. Wilentz, R.E. Wilentz, ROBB E. WILENTZ, Robb E Wilentz, Robb E. Wilentz, Robb Wilentz

Publications

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Johns Hopkins Hospital University of Amsterdam Memorial Sloan Kettering Cancer Center

About

Robb E. Wilentz is an author at Johns Hopkins University specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	26	4.8K
2	Cell Biology	13	13	2.6K
3	Health Sciences	1	1	135
4	Public Health	1	1	308
5	Epidemiology	1	1	308

Robb E. Wilentz

Publications

8.1K

Citations

H-Index

Page 1

	Year	Citations
Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Robb E. Wilentz, Christine A. Iacobuzio–Donahue, Pedram Argani, PubMed ImmunologyPathologyPancreatic Intraepithelial NeoplasiaDpc4 InactivationDpc4 Expression	2000	592
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Pedram Argani, Christine A. Iacobuzio–Donahue, Byungwoo Ryu, PubMed	2001	578
Solid-Pseudopapillary Tumors of the Pancreas Are Genetically Distinct from Pancreatic Ductal Adenocarcinomas and Almost Always Harbor β-catenin Mutations Susan C. Abraham, David S. Klimstra, Robb E. Wilentz, American Journal Of Pathology Pancreatic CancerPathologyPancreatic SurgeryPancreatic Ductal AdenocarcinomasSolid-pseudopapillary Tumors	2002	486
Telomere Shortening Is Nearly Universal in Pancreatic Intraepithelial Neoplasia N. Tjarda van Heek, Alan K. Meeker, Scott E. Kern, American Journal Of Pathology Tumor BiologyPancreatic CancerPathologyPancreatic Intraepithelial NeoplasiaMolecular Pathology	2002	362
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Robb E. Wilentz, Joseph Geradts, Robert Maynard, PubMed PathologyCancer BiologyTumor BiologyTranscriptional RegulationPancreatic Cancer	1998	340
Pancreaticoduodenectomy (Whipple Resections) in Patients Without Malignancy Susan C. Abraham, Robb E. Wilentz, Charles J. Yeo, The American Journal of Surgical Pathology Pancoast SyndromeSurgical OncologyPancreatic CancerPancreas DivisumPancreatic Fluid Collection	2003	337
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Pedram Argani, Christophe Rosty, Robert E. Reiter, PubMed Serial AnalysisOnline Sage DatabasePancreatic CancerNew MarkersSage Libraries	2001	320
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Metin Tascilar, Halcyon G. Skinner, Christophe Rosty, PubMed	2001	310
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Anne C. Tersmette, Gloria M. Petersen, G.J.A. Offerhaus, PubMed Family MedicineFirst-degree RelativesPc RiskEpidemiology Of CancerGenetic Epidemiology	2001	308
Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas Robb E. Wilentz, Gloria H. Su, Jia Le Dai, American Journal Of Pathology Tumor BiologyPancreatic CancerMedicinePathologyCancer Genomics	2000	303

Page 1